Cerebrovascular Collaterals Correlate with Disease Severity in Adult North American Patients with Moyamoya Disease

References

1. 1.↵
   1. Khan N,
   2. Achrol AS,
   3. Guzman R,
   4. et al

   . Sex differences in clinical presentation and treatment outcomes in moyamoya disease. Neurosurgery 2012;71:587–93, discussion 593

   CrossRefPubMed
2. 2.↵
   1. Bao XY,
   2. Duan L,
   3. Li DS,
   4. et al

   . Clinical features, surgical treatment and long-term outcome in adult patients with moyamoya disease in China. Cerebrovasc Dis 2012;34:305–13

   CrossRefPubMed
3. 3.↵
   1. Han DH,
   2. Kwon OK,
   3. Byun BJ,
   4. et al.

   , for the Korean Society for Cerebrovascular Disease. A co-operative study: clinical characteristics of 334 Korean patients with moyamoya disease treated at neurosurgical institutes (1976–1994): the Korean Society for Cerebrovascular Disease. Acta Neurochir (Wien) 2000;142:1263–74, discussion 1273–74

   CrossRefPubMed
4. 4.↵
   1. Duan L,
   2. Bao XY,
   3. Yang WZ,
   4. et al

   . Moyamoya disease in China: its clinical features and outcomes. Stroke 2012;43:56–60

   Abstract/FREE Full Text
5. 5.↵
   1. Zipfel GJ,
   2. Sagar J,
   3. Miller JP,
   4. et al

   . Cerebral hemodynamics as a predictor of stroke in adult patients with moyamoya disease: a prospective observational study. Neurosurg Focus 2009;26:E6

   PubMed
6. 6.↵
   1. Chiu D,
   2. Shedden P,
   3. Bratina P,
   4. et al

   . Clinical features of moyamoya disease in the U.S. Stroke 1998;29:1347–51

   Abstract/FREE Full Text
7. 7.↵
   1. Lee DJ,
   2. Liebeskind DS

   . Characterization of inpatient moyamoya in the U.S.: 1988–2004. Front Neurol 2011;2:43

   PubMed
8. 8.↵
   1. Kainth D,
   2. Chaudhry SA,
   3. Kainth H,
   4. et al

   . Epidemiological and clinical features of moyamoya disease in the USA. Neuroepidemiology 2013;40:282–87

   CrossRefPubMed
9. 9.↵
   1. Hallemeier CL,
   2. Rich KM,
   3. Grubb RL,
   4. et al

   . Clinical features and outcome in North American adults with moyamoya phenomenon. Stroke 2006;37:1490–96

   Abstract/FREE Full Text
10. 10.↵
    1. Krischek B,
    2. Kasuya H,
    3. Khan N,
    4. et al

    . Genetic and clinical characteristics of moyamoya disease in Europeans. Acta Neurochir Suppl 2011;112:31–34

    CrossRefPubMed
11. 11.↵
    1. Suzuki J,
    2. Kodama N

    . Moyamoya disease: a review. Stroke 1983;14:104–09

    Abstract/FREE Full Text
12. 12.↵
    1. Kuroda S,
    2. Hashimoto N,
    3. Yoshimoto T,
    4. et al

    . Radiological findings, clinical course, and outcome in asymptomatic moyamoya disease: results of multicenter survey in Japan. Stroke 2007;38:1430–35

    Abstract/FREE Full Text
13. 13.↵
    1. Nariai T,
    2. Matsushima Y,
    3. Imae S,
    4. et al

    . Severe haemodynamic stress in selected subtypes of patients with moyamoya disease: a positron emission tomography study. J Neurol Neurosurg Psychiatry 2005;76:663–69

    Abstract/FREE Full Text
14. 14.↵
    1. Scott RM,
    2. Smith ER

    . Moyamoya disease and moyamoya syndrome. N Engl J Med 2009;360:1226–37

    CrossRefPubMedWeb of Science
15. 15.↵
    1. Morioka M,
    2. Hamada JI,
    3. Kawano T,
    4. et al

    . Angiographic dilatation and branch extension of the anterior choroidal and posterior communicating arteries are predictors of hemorrhage in adult moyamoya patients. Stroke 2003;34:90–95

    Abstract/FREE Full Text
16. 16.↵
    1. Suzuki J,
    2. Takaku A

    . Cerebrovascular “moyamoya” disease. Disease showing abnormal net-like vessels in base of brain. Arch Neurol 1969;20:288–99

    CrossRefPubMedWeb of Science
17. 17.↵
    1. Mugikura S,
    2. Takahashi S,
    3. Higano S,
    4. et al

    . Predominant involvement of ipsilateral anterior and posterior circulations in moyamoya disease. Stroke 2002;33:1497–500

    Abstract/FREE Full Text
18. 18.↵
    1. Donahue MJ,
    2. Ayad M,
    3. Moore R,
    4. et al

    . Relationships between hypercarbic reactivity, cerebral blood flow, and arterial circulation times in patients with moyamoya disease. J Magn Reson Imaging 2013;38:1129–39

    CrossRefPubMed
19. 19.↵
    1. Bokkers RP,
    2. van Laar PJ,
    3. van de Ven KC,
    4. et al

    . Arterial spin-labeling MR imaging measurements of timing parameters in patients with a carotid artery occlusion. AJNR Am J Neuroradiol 2008;29:1698–703

    Abstract/FREE Full Text
20. 20.↵
    1. Togao O,
    2. Mihara F,
    3. Yoshiura T,
    4. et al

    . Cerebral hemodynamics in moyamoya disease: correlation between perfusion-weighted MRI and cerebral angiography. AJNR Am J Neuroradiol 2006;27:391–97

    Abstract/FREE Full Text
21. 21.↵
    1. Kaku Y,
    2. Morioka M,
    3. Ohmori Y,
    4. et al

    . Outer-diameter narrowing of the ICA and MCA in moyamoya disease detected on 3D constructive interference in steady-state MR image: is arterial constrictive remodeling a major pathogenesis? Acta Neurochir (Wien) 2012;154:2151–57

    CrossRefPubMed
22. 22.↵
    1. Hishikawa T,
    2. Tokunaga K,
    3. Sugiu K,
    4. et al

    . Clinical and radiographic features of moyamoya disease in patients with both cerebral ischemia and hemorrhage. Br J Neurosurg 2013;27:198–201

    CrossRefPubMed
23. 23.↵
    1. Touloumis A

    . multgee: GEE solver for Correlated Nomiinal or Ordianal Multinomial Responses, Version 1.3. http://cran.r-project.org/package=multgee
24. 24.↵
    1. Czabanka M,
    2. Pena-Tapia P,
    3. Schubert GA,
    4. et al

    . Proposal for a new grading of moyamoya disease in adult patients. Cerebrovasc Dis 2011;32(1):41–50

    CrossRefPubMed
25. 25.↵
    1. Liebeskind DS,
    2. Cotsonis GA,
    3. Saver JL,
    4. et al

    . Collaterals dramatically alter stroke risk in intracranial atherosclerosis. Ann Neurol 2011;69:963–74

    CrossRefPubMed
26. 26.↵
    1. Liebeskind DS,
    2. Cotsonis GA,
    3. Saver JL,
    4. et al

    . Collateral circulation in symptomatic intracranial atherosclerosis. J Cereb Blood Flow Metab 2011;31:1293–301

    CrossRefPubMed
27. 27.↵
    1. Huang AP,
    2. Liu HM,
    3. Lai DM,
    4. et al

    . Clinical significance of posterior circulation changes after revascularization in patients with moyamoya disease. Cerebrovasc Dis 2009;28:247–57

    CrossRefPubMed
28. 28.↵
    1. Hendrikse J,
    2. Hartkamp MJ,
    3. Hillen B,
    4. et al

    . Collateral ability of the circle of Willis in patients with unilateral ICA occlusion. Stroke 2001;32:2768–73

    Abstract/FREE Full Text
29. 29.↵
    1. Kleinloog R,
    2. Regli L,
    3. Rinkel GJ,
    4. et al

    . Regional differences in incidence and patient characteristics of moyamoya disease: a systematic review. J Neurol Neurosurg Psychiatry 2012;83:531–36

    Abstract/FREE Full Text
30. 30.↵
    1. Mesiwala AH,
    2. Sviri G,
    3. Fatemi N,
    4. et al

    . Long-term outcome of superficial temporal artery-MCA bypass for patients with moyamoya disease in the US. Neurosurg Focus 2008;24:E15

    PubMed
31. 31.↵
    1. Liu W,
    2. Zhu S,
    3. Wang X,
    4. et al

    . Evaluation of angiographic changes of the anterior choroidal and posterior communicating arteries for predicting cerebrovascular lesions in adult moyamoya disease. J Clin Neurosci 2011;18:374–78

    CrossRefPubMed
32. 32.↵
    1. Wetjen NM,
    2. Garell PC,
    3. Stence NV,
    4. et al

    . Moyamoya disease in the Midwestern United States. Neurosurg Focus 1998;5:e1

    PubMed
33. 33.↵
    1. Fukui M,
    2. Kono S,
    3. Sueishi K,
    4. et al

    . Moyamoya disease. Neuropathology 2000;20(suppl):S61–S64

    CrossRefPubMedWeb of Science
34. 34.↵
    1. Fukui M

    . Guidelines for the diagnosis and treatment of spontaneous occlusion of the circle of Willis (‘moyamoya’ disease). Research Committee on Spontaneous Occlusion of the Circle of Willis (Moyamoya Disease) of the Ministry of Health and Welfare, Japan. Clin Neurol Neurosurg 1997;99(suppl 2):S238–S240

    PubMedWeb of Science
35. 35.↵
    1. Okada Y,
    2. Shima T,
    3. Nishida M,
    4. et al

    . Effectiveness of superficial temporal artery-MCA in adult moyamoya disease: cerebral hemodynamics and clinical course in ischemic and hemorrhagic varieties. Stroke 1998;29:625–30

    Abstract/FREE Full Text
36. 36.↵
    1. Nah HW,
    2. Kwon SU,
    3. Kang DW,
    4. et al

    . Moyamoya disease-related versus primary intracerebral hemorrhage. Stroke 2012;7:1947–50
37. 37.↵
    1. Dolati P,
    2. Sutherland G,
    3. Wong J,
    4. et al

    . Distal anterior choroidal artery aneurysm following iatrogenic posterior cerebral artery occlusion: a case report and review of literature. Acta Neurochir (Wien) 2012;154:53–57

    CrossRefPubMed
38. 38.↵
    1. Yamada I,
    2. Himeno Y,
    3. Suzuki S,
    4. et al

    . Posterior circulation in moyamoya disease: angiographic study. Radiology 1995;197:239–46

    CrossRefPubMed
39. 39.↵
    1. Bang OY,
    2. Saver JL,
    3. Kim SJ,
    4. et al

    . Collateral flow averts hemorrhagic transformation after endovascular therapy for acute ischemic stroke. Stroke 2011;42:2235–39

    Abstract/FREE Full Text
40. 40.↵
    1. Yamauchi H,
    2. Kudoh T,
    3. Sugimoto K,
    4. et al

    . Patterns of collaterals, type of infarcts, and hemodynamic impairment in carotid artery occlusion. J Neurol Neurosurg Psychiatry 2004;75:1697–701

    Abstract/FREE Full Text
41. 41.↵
    1. Vajkoczy P

    . Moyamoya disease: collateralization is everything. Cerebrovasc Dis 2009;28:258

    CrossRefPubMed
42. 42.↵
    1. Lim SM,
    2. Chae EJ,
    3. Kim MY,
    4. et al

    . Steal phenomenon through the anterior communicating artery in moyamoya disease. Eur Radiol 2007;17:61–66

    CrossRefPubMed
43. 43.↵
    1. Wakai K,
    2. Tamakoshi A,
    3. Ikezaki K,
    4. et al

    . Epidemiological features of moyamoya disease in Japan: findings from a nationwide survey. Clin Neuro Neurosurg 1997;99(suppl 2):S1–S5

    CrossRef